Stay updated on Nivolumab and Ipilimumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Ipilimumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Ipilimumab in Melanoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Melanoma and MedlinePlus Genetics related topics were removed from the page's related topics section.
    Difference
    0.3%
    Check dated 2025-11-03T12:49:01.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The page now includes Melanoma and MedlinePlus Genetics under Related Topics, serving as navigation aids and context rather than altering trial content; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-10-27T08:54:41.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Removed the MedlinePlus Genetics topic on Melanoma. This reduces coverage of melanoma-related genetic information on the page.
    Difference
    0.1%
    Check dated 2025-10-20T05:47:01.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    Summary: The page now announces a government funding lapse with current operating status guidance and upgrades the version from v3.1.0 to v3.2.0.
    Difference
    2%
    Check dated 2025-10-05T17:21:00.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Updated the page from revision v3.0.2 to v3.1.0, signaling a new release version.
    Difference
    0.1%
    Check dated 2025-09-28T10:13:00.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Revision updated to v3.0.2; removed 'Back to Top' element.
    Difference
    0.1%
    Check dated 2025-09-14T00:16:19.000Z thumbnail image

Stay in the know with updates to Nivolumab and Ipilimumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Ipilimumab in Melanoma Clinical Trial page.